This company has been acquired

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Tyme Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NasdaqCM:TYME - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2022	N/A	-24	-20	-20	N/A
3/31/2022	N/A	-24	-21	-21	N/A
12/31/2021	N/A	-24	-19	-19	N/A
9/30/2021	N/A	-25	-21	-21	N/A
6/30/2021	N/A	-26	-23	-23	N/A
3/31/2021	N/A	-29	-24	-24	N/A
12/31/2020	N/A	-28	-24	-24	N/A
9/30/2020	N/A	-28	-23	-23	N/A
6/30/2020	N/A	-28	-20	-20	N/A
3/31/2020	N/A	-22	-20	-20	N/A
12/31/2019	N/A	-27	-18	-18	N/A
9/30/2019	N/A	-29	-19	-19	N/A
6/30/2019	N/A	-29	-19	-19	N/A
3/31/2019	N/A	-33	-20	-20	N/A
12/31/2018	N/A	-27	-20	-20	N/A
9/30/2018	N/A	-25	-17	-17	N/A
6/30/2018	N/A	-23	-15	-15	N/A
3/31/2018	N/A	-19	-12	-12	N/A
12/31/2017	N/A	-17	-10	-10	N/A
9/30/2017	N/A	-14	-9	-9	N/A
6/30/2017	N/A	-12	-7	-7	N/A
3/31/2017	N/A	-15	-6	-6	N/A
12/31/2016	N/A	-17	-6	-6	N/A
6/30/2016	N/A	-13	-6	-6	N/A
3/31/2016	N/A	-11	N/A	-5	N/A
12/31/2015	N/A	-12	N/A	-7	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if TYME's forecast earnings growth is above the savings rate (1.9%).

Earnings vs Market: Insufficient data to determine if TYME's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if TYME's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if TYME's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if TYME's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if TYME's Return on Equity is forecast to be high in 3 years time

This company has been acquired

Tyme Technologies Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Price target increased to US$9.44

Recent updates

Tyme Technologies, Inc.(NasdaqCM:TYME) dropped from NASDAQ Composite Index

Tyme Technologies, Inc. Announces Board Changes

Syros, Tyme Technologies jump more than 20% after hours as shareholders approve merger

We Think Tyme Technologies (NASDAQ:TYME) Can Afford To Drive Business Growth

Tyme Technologies, Inc. (NasdaqCM:TYME) entered into a definitive merger agreement to acquire Tyme Technologies, Inc. (NasdaqGS:SYRS) from Adage Capital Partners, L.P., Samsara Biocapital, L.P., Jalaa Equities, L.P., Flagship Pioneering Fund VII, CVI Investments, Inc. and others for $67.6 million.

TYME stock surges on merger agreement and Syros Pharmaceuticals

Tyme Technologies Receives Extension to Regain Compliance with the Nasdaq Continued Listing Standards

Tyme Technologies: Net-Net Biopharma Exploring Strategic Alternatives

Co-Founder & Director notifies of intention to sell stock

Co-Founder & Director notifies of intention to sell stock

Insufficient new directors

Insufficient new directors

We Think Tyme Technologies (NASDAQ:TYME) Can Afford To Drive Business Growth

Co-Founder notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

Tyme Technologies, Inc. to Report Q3, 2022 Results on Feb 11, 2022

Tyme Technologies, Inc. Provides Update on Precision Promise Trial in Metastatic Pancreatic Cancer

Tyme Technologies, Inc. Announces Additional Encouraging Preclinical Data on the Effect of TYME-19 in SARS CoV-2 Infections

Tyme Technologies Offers Incredible Risk-Reward

Here's Why We're Not Too Worried About Tyme Technologies' (NASDAQ:TYME) Cash Burn Situation

Co-Founder notifies of intention to sell stock

TYME Technologies, Inc. Announces First Patient Dosed in Phase II OASIS Trial Evaluating the Potential Benefits of Oral SM-88 for Patients with Metastatic HR+/HER2- Breast Cancer After Treatment with a CDK4/6 Inhibitor

Independent Director recently bought US$52k worth of stock

Tyme Technologies: The Market Missed The Bullish Memo

Co-Founder notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

We're Not Very Worried About Tyme Technologies' (NASDAQ:TYME) Cash Burn Rate

Tyme Technologies, Inc.(NasdaqCM:TYME) dropped from Russell 3000 Growth Index

Tyme Technologies reports FY results

Tyme Technologies: Recent Sell-Off Provides Opportunity To Buy At A Discount

Co-Founder notifies of intention to sell stock

Price target increased to US$9.44

Chief Medical Officer has left the company

Here's Why We're Watching Tyme Technologies' (NASDAQ:TYME) Cash Burn Situation

Insider recently sold US$55k worth of stock

Have Tyme Technologies, Inc. (NASDAQ:TYME) Insiders Been Selling Their Stock?

Insider recently sold US$55k worth of stock

Tyme falls after equity offer as quarterly data indicate liquidity pressure

New 90-day high: US$3.53

Tyme stock granted U.S. patent claims for using TYME-19 to treat COVID-19 infections

Do Institutions Own Tyme Technologies, Inc. (NASDAQ:TYME) Shares?

Co-Founder notifies of intention to sell stock

New 90-day high: US$1.34

Revisiting Tyme Technologies

Co-Founder recently sold US$613k worth of stock

Co-Founder notifies of intention to sell stock

Have Insiders Sold Tyme Technologies, Inc. (NASDAQ:TYME) Shares Recently?

Is Tyme Technologies (NASDAQ:TYME) In A Good Position To Invest In Growth?

Tyme Technologies, Inc. Announces Executive Changes

New 90-day high: US$1.05

Tyme Technologies names new finance chief

Tyme Technologies, Inc. Announces Resignation of Ben R. Taylor as Chief Financial Officer

New 90-day low: US$0.92

Co-Founder notifies of intention to sell stock

Tyme Technologies, Inc. Announces Executive Changes

New 90-day low - US$0.98

New 90-day low - US$1.17

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies